An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.
An advanced imaging approach is showing promise in improving prostate cancer detection by providing doctors with a clearer image of suspected tumours during the biopsy.
According to recent study, prostate artery embolization (PAE) is an effective long-term treatment for urinary problems brought on by an enlarged prostate gland.
Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered critical molecular players that drive prostate cancer to progress into a highly aggressive form of neuroendocrine prostate cancer that currently
SPOP is the most mutated protein in prostate cancer and plays a role in endometrial, uterine and other cancers. Despite this importance, how SPOP mutations drive cancer has been incompletely understood. Scientists at St. Jude Children's Research Hospital used cryo-electron microscopy (cryo-E
Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio', a blood test to help in the diagnosis of brain tumors. This is the thir
A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial College London, U.K., and colleagues present these findings in t
New Delhi [India], December 24 (ANI/PNN): For the past 20 years there hasn't been a major innovation in fiber laser technology until the launch of Super Pulsed Thulium fiber laser. The TFL laser is advanced technology that can dust stones in half the time it takes on other laser systems. Thi
Researchers have described prostate cancer cell dynamics at a single-cell resolution across the whole course of the disease, from the first stages to the point of androgen independence, where the tumour stops responding to hormone restriction therapy.
From the onset of the disease through the point of androgen independence, where the tumour no longer responds to hormone restriction therapy, researchers have described prostate cancer cell dynamics at a single-cell resolution over the course of the disease.